SBI Life Insurance Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

June 25, 2026
Posted by: Kunal Singla
Category: News

SBI Life Insurance Q1 Results FY27: Uniresearch projects Revenue Rs 50,539 Cr | PAT Rs 699 Cr (36-analyst consensus). Q4 FY26: Rev Rs 4,071 Cr | PAT Rs 805 Cr.

The SBI Life Insurance Q1 Results FY27 outlook is anchored on Q4 FY26 verified actuals and Uniresearch analysis applying the 36-analyst FY27 consensus to Q1 FY26 verified actuals. Uniresearch projects Revenue Rs 50,539 Cr (+29.6% YoY) and PAT Rs 699 Cr (+17.7% YoY). Prepared by Ankit Jaiswal.

Click Here – Get Free Investment Predictions

Table of Contents

SBI Life Insurance Q1 Results FY27 – Uniresearch Prediction

Metric	Q1 FY26 Actual	Q1 Results FY27 Uniresearch Prediction	YoY Change	Source
SBI Life Insurance Revenue (Rs Cr)	38,996	50,539	+29.6%	Uniresearch \| 36-analyst consensus applied to Q1 FY26 verified actual
PAT (Rs Cr)	594	699	+17.7%	Uniresearch \| 36-analyst consensus applied to Q1 FY26 verified actual
Avg Analyst Target	Rs 2,341	12-month view	–	Analyst consensus (36 analysts)

Predictions apply 36-analyst FY27 consensus (Rev +29.6%, PAT +17.7%) to Q1 FY26 verified actuals. Not guaranteed outcomes.

SBI Life Insurance Q4 FY26 Key Metrics – Baseline for SBI Life Insurance Q1 Results FY27

Metric	Q4 FY26 Actual	YoY Change	Source
Revenue (Rs Cr)	4,071	-82.4% YoY	Consolidated quarterly financial data
PAT (Rs Cr)	805	-1.1% YoY	Consolidated quarterly financial data

What Analysts Are Saying About SBI Life Insurance Q1 Results FY27

Across 36 analysts covering SBI Life Insurance, the FY27 consensus projects revenue growth of +29.6% and profit growth of +17.7%, with an average 12-month price target of Rs 2,341. The Q1 Results FY27 prediction reflects this consensus applied to verified Q1 FY26 actuals.

Key Watchpoints for SBI Life Insurance

Revenue Delivery vs Consensus for SBI Life Insurance

The primary watchpoint is whether Revenue in Q1 Results FY27 delivers in line with the Uniresearch projection of Rs 50,539 Cr (+29.6% consensus growth). Q1 FY26 base was Rs 38,996 Cr.

PAT Performance in Q1 Results FY27

The PAT watchpoint is whether SBI Life Insurance achieves Rs 699 Cr (+17.7% growth from Q1 FY26 base of Rs 594 Cr). Q4 FY26 PAT was Rs 805 Cr.

Risks to the SBI Life Insurance Prediction

Below-Consensus Revenue Growth

If Revenue comes in below the +29.6% consensus, actual revenue would fall short of Rs 50,539 Cr.

PAT Pressure in Q1 Results FY27

The PAT prediction of Rs 699 Cr could be impacted by cost escalation not factored into the 36-analyst consensus of +17.7%.

Conclusion: SBI Life Insurance

The SBI Life Insurance Uniresearch prediction of Revenue Rs 50,539 Cr and PAT Rs 699 Cr is derived from the 36-analyst consensus FY27 growth rates applied to verified Q1 FY26 actuals. When Q1 Results FY27 are declared, investors can benchmark actual performance against this consensus prediction. Track live updates on Univest.

Track SBI Life Insurance Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live Q1 Results FY27 alerts.

Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals – these are analyst consensus projections and are not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.

Frequently Asked Questions on SBI Life Insurance

What is Uniresearch’s PAT prediction for SBI Life Insurance Q1 Results FY27?

Ans. Uniresearch projects SBI Life Insurance PAT at Rs 699 Cr, applying 36-analyst FY27 profit growth consensus of +17.7% to Q1 FY26 verified PAT of Rs 594 Cr.

What is the Revenue prediction for SBI Life Insurance Q1 Results FY27?

Ans. SBI Life Insurance Revenue is projected at Rs 50,539 Cr, applying +29.6% FY27 revenue consensus to verified Q1 FY26 base.

What were SBI Life Insurance Q1 Results FY27?

Ans. Q4 FY26 consolidated Revenue was Rs 4,071 Cr (-82.4% YoY) and PAT was Rs 805 Cr (-1.1% YoY).

Does the SBI Life Insurance Q1 Results FY27?

Ans. No. All predictions in this article are derived from the 36-analyst consensus applied to verified Q1 FY26 actuals.

What is the analyst target price mentioned in the SBI Life Insurance Q1 Results FY27?

Ans. The 36-analyst consensus gives an average 12-month price target of Rs 2,341 for SBI Life Insurance.

What are the risks to the SBI Life Insurance Q1 Results FY27?

Ans. Risks include below-consensus revenue growth (target: +29.6%) and unexpected cost pressures impacting the +17.7% PAT consensus.

What is the Q1 FY26 base for the SBI Life Insurance Q1 Results FY27?

Ans. Q1 FY26 consolidated Revenue was Rs 38,996 Cr and PAT was Rs 594 Cr. These form the base for the SBI Life Insurance prediction.

News

Author: Kunal Singla

Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.